Official Title
Evaluation Of Cognitive Functions In Adult Individuals With COVID-19
Brief Summary

This study was aimed to evaluate the post-infection cognitive functions of adult individuals with COVID-19. 50 individuals with COVID-19 and 50 healthy control groups were included in the study. Cognitive functions of individuals with COVID19 compared with healthy individuals.

Detailed Description

This study was aimed to evaluate the post-infection cognitive functions of adult individuals

with COVID-19. Fifty COVID-19 patients, aged between 18-50 years, who had positive RT-PCR

test in the last 60 days and later recovered, were included in the study. The study group was

compared with the control group consisting of 50 healthy individuals in whom gender, age and

education year has not difference significantly. Participants' global cognitive skills were

measured by the Montreal Cognitive Assessment Test (MoCA), the Clock Drawing Test and memory

functions, the Öktem Verbal Memory Processes Test (Ö-SBST), the attention functions by the

Digit Span Forward and Digit Span Backwards Test, the executive functions by Categorical

Fluency, Phonemic Fluency, the Stroop Test, Trail Making Test A and B, visuospatial skills

were evaluated with the Rey-Osterrieth Complex Figure Test (ROCF), and behavioral symptoms

were evaluated with the Neuropsychiatric Inventory (NPI). The study group was evaluated

between 21 and 60 days from the onset of the disease.

Active, not recruiting
COVID-19 Acute Respiratory Distress Syndrome
Cognitive Decline

Behavioral: Neuropsychometric Test
Participants' global cognitive skills were measured by the Montreal Cognitive Assessment Test (MoCA), the Clock Drawing Test and memory functions, the Öktem Verbal Memory Processes Test (Ö-SBST), the attention functions by the Digit Span Forward and Digit Span Backwards Test, the executive functions by Categorical Fluency, Phonemic Fluency, the Stroop Test, Trail Making Test A and B, visuospatial skills were evaluated with the Rey-Osterrieth Complex Figure Test (ROCF), and behavioral symptoms were evaluated with the Neuropsychiatric Inventory (NPI).
Control Group
Study Group
Other Name: Montreal Cognitive Assessment Test (MoCA)
Other Name: Clock Drawing Test
Other Name: Öktem Verbal Memory Processes Test (Ö-SBST)
Other Name: Digit Span Forward Test
Other Name: Digit Span Backwards Test
Other Name: Categorical Fluency
Other Name: Phonemic Fluency
Other Name: Stroop Test
Other Name: Trail Making Test A
Other Name: Trail Making Test B
Other Name: Rey-Osterrieth Complex Figure Test (ROCF)
Other Name: Neuropsychiatric Inventory (NPI)

Eligibility Criteria

Inclusion Criteria: - Having positive for the COVID-19 RT-PCR test and turned negative in the last 60 days. - be 18-50 years old - 21 days have passed since the onset of the disease

Exclusion Criteria: - Having any neurological or psychiatric illness

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years~Maximum: 50 Years
Countries
Turkey

Büşra Tüfekçi
Principal Investigator
Medipol University

Medipol University
NCT Number
Keywords
Cognitive Functions
Covid-19
MeSH Terms
Respiratory Distress Syndrome, Newborn
Respiratory Distress Syndrome, Adult
Acute Lung Injury
Cognitive Dysfunction